Genetic
- Phone: +48 91 433 42 56
- Email: office@read-gene.com
- Address: Grzepnica, ul. Alabastrowa 8, 72-003 Dobra (Szczecińska)
Menu
Recommended element concentrations
The following standards were established on the basis of the Center's own research. Optimal concentration ranges are correlated with a reduced risk of cancer in adults (over 18 years of age). For more information about our research, please read our research.
Elemental norms have not yet been established for some groups of patients based on prospective observations of cohorts of Polish patients. We mark this situation as "NZ". These relationships may be observed as a result of further work. Before choosing the type of elements to be tested, please read the table of current standards.
In patients under 18 years of age, the optimal concentration of elements has not yet been determined in the Polish population.
Ostatnia aktualizacja – 5.10.2026 r.
| Element | Group | Subgroup | Norm [µg/l] | Publication/Patent application number |
| Selenium | Women BRCA1 (-) | – | 113-130 | P.456891 |
| Women BRCA1 (+) | < 50 yo | 96-102 | P.439318 | |
| > 50 yo | 95-120 | |||
| Men | – | 115-130 | P.456890 | |
| Person under 18 years of age | – | 64-110 | Katarina Osman, et al. Clinical Biochemistry (Vol. 31, No. 8, 657-665, 1998) | |
| Arsenic * | Women BRCA1 (-) | – | < 0,6 | Marciniak W., 2020, P.439315 |
| Women BRCA1 (+) | – | < 0,85 | Marciniak W., 2021 | |
| Men | – | 0,7-1,14 | Pat.243835 | |
| Person under 18 years of age | – | NZ* | – | |
| Cadmium | Women BRCA1 (-) | – | <0,6 | Pat.243866 |
| Women BRCA1 (+) | – | < 0,27 | Pat.237085 | |
| Men | – | < 0,21 | Pat.243863 | |
| Person under 18 years of age | – | NZ* | – | |
| Zinc | Women BRCA1 (-) | – | 5600-6100 | Pat.243832 |
| Women BRCA1 (+) | Non-smokers | 6000-6700 | P.439319 | |
| Smokers | 6400-6800 | |||
| Men | – | 6000-6500 | Pat.243833 | |
| Person under 18 years of age | – | NZ* | – | |
| Copper ** | Women BRCA1 (-) | < 50 yo | 850-1000 | P.438572 |
| > 50 yo | < 1000 | |||
| Women BRCA1 (+) | Non-smokers < 50 yo | 750-825 | ||
| Non-smokers > 50 yo | < 1000 | |||
| Smokers | < 1000 | |||
| Men | – | < 800 | Pat.243834 | |
| Person under 18 years of age | – | NZ* | – | |
| Lead | Women BRCA1 (-) | – | ≤ 7,5 | P.438655 |
| Women BRCA1 (+) | – | < 8 | P.433150 | |
| Men | – | < 13,5 | Pat.243865 | |
| Person under 18 years of age | – | NZ* | – |
- NZ - so far, no correlation has been found between the concentration of the element and the risk of cancer in this clinical subgroup
- Women BRCA1 (-) – women without a detected mutation in the BRCA1 gene
- Women BRCA1 (+) – women with a detected mutation in the BRCA1 gene
- Non-smokers
- Smokers
- * Level of arsenic below 0.6 µg/l in the blood in women over 40 years of age may be the expected concentration if a diet low in arsenic is used, but it may also be a parameter/marker indicating the developing malignant tumor of the large intestine. It is recommended to do this to rule out this possibility control colonoscopy (Baszuk i wsp., 2021).
- ** Level of copper powyżej 1000 µg/l we krwi u kobiet oraz stężenie miedzi powyżej 800 µg/l we krwi u mężczyzn może wskazywać na rozwijający się nowotwór złośliwy jelita grubego. W celu wykluczenia tej możliwości wskazane jest wykonanie control colonoscopy (Baszuk i wsp., 2021).
| Element | Group | Norm [µg/l] | Publication/ Patent application number |
| Selenium | Women | 95-102,5 | Lener M, 2016 Lubiński JA, 2018 Lubiński J, 20118 Pietrzak S, 2019 Szwiec M, 2021 Rogoża-Janiszewska E., 2021 P.437046 |
| Men | 95-102,5 | ||
| Person under 18 years of age | NZ* | – | |
| Arsenic | Women | NZ* | – |
| Men | 0,75-1,0 | P.437046 | |
| Person under 18 years of age | NZ* | – | |
| Zinc | - | 1025-1175 | Lubiński J, 2021 P.434767 P.437046 |
| Person under 18 years of age | NZ* | – | |
| Copper | - | <1000 ≤ 900 | P.436999 |
| Person under 18 years of age | NZ* | – | |
| Manganese | Women | 1-10 | P.438040 |
| Men | NZ* | – | |
| Person under 18 years of age | NZ* | – | |
| Chromium | Women | >0,5 | P.438042 |
| Men | NZ* | – | |
| Person under 18 years of age | NZ* | – |
Recommended element concentrations
The following standards were established on the basis of the Center's own research. Optimal concentration ranges are correlated with a reduced risk of cancer in adults (over 18 years of age). For more information about our research, please read our research.
Elemental norms have not yet been established for some groups of patients based on prospective observations of cohorts of Polish patients. We mark this situation as "NZ". These relationships may be observed as a result of further work. Before choosing the type of elements to be tested, please read the table of current standards.
In patients under 18 years of age, the optimal concentration of elements has not yet been determined in the Polish population.
Ostatnia aktualizacja – 5.10.2026 r.
| Element | Group | Subgroup | Norm [µg/l] | Publication/Patent application number |
| Selenium | Women BRCA1 (-) | – | 113-130 | P.456891 |
| Women BRCA1 (+) | < 50 yo | 96-102 | P.439318 | |
| > 50 yo | 95-120 | |||
| Men | – | 115-130 | P.456890 | |
| Person under 18 years of age | – | 64-110 | Katarina Osman, et al. Clinical Biochemistry (Vol. 31, No. 8, 657-665, 1998) | |
| Arsenic * | Women BRCA1 (-) | – | < 0,6 | Marciniak W., 2020, P.439315 |
| Women BRCA1 (+) | – | < 0,85 | Marciniak W., 2021 | |
| Men | – | 0,7-1,14 | Pat.243835 | |
| Person under 18 years of age | – | NZ* | – | |
| Cadmium | Women BRCA1 (-) | – | <0,6 | Pat.243866 |
| Women BRCA1 (+) | – | < 0,27 | Pat.237085 | |
| Men | – | < 0,21 | Pat.243863 | |
| Person under 18 years of age | – | NZ* | – | |
| Zinc | Women BRCA1 (-) | – | 5600-6100 | Pat.243832 |
| Women BRCA1 (+) | Non-smokers | 6000-6700 | P.439319 | |
| Smokers | 6400-6800 | |||
| Men | – | 6000-6500 | Pat.243833 | |
| Person under 18 years of age | – | NZ* | – | |
| Copper ** | Women BRCA1 (-) | < 50 yo | 850-1000 | P.438572 |
| > 50 yo | < 1000 | |||
| Women BRCA1 (+) | Non-smokers < 50 yo | 750-825 | ||
| Non-smokers > 50 yo | < 1000 | |||
| Smokers | < 1000 | |||
| Men | – | < 800 | Pat.243834 | |
| Person under 18 years of age | – | NZ* | – | |
| Lead | Women BRCA1 (-) | – | ≤ 7,5 | P.438655 |
| Women BRCA1 (+) | – | < 8 | P.433150 | |
| Men | – | < 13,5 | Pat.243865 | |
| Person under 18 years of age | – | NZ* | – |
- NZ - so far, no correlation has been found between the concentration of the element and the risk of cancer in this clinical subgroup
- Women BRCA1 (-) – women without a detected mutation in the BRCA1 gene
- Women BRCA1 (+) – women with a detected mutation in the BRCA1 gene
- Non-smokers
- Smokers
- * Level of arsenic below 0.6 µg/l in the blood in women over 40 years of age may be the expected concentration if a diet low in arsenic is used, but it may also be a parameter/marker indicating the developing malignant tumor of the large intestine. It is recommended to do this to rule out this possibility control colonoscopy (Baszuk i wsp., 2021).
- ** Level of copper powyżej 1000 µg/l we krwi u kobiet oraz stężenie miedzi powyżej 800 µg/l we krwi u mężczyzn może wskazywać na rozwijający się nowotwór złośliwy jelita grubego. W celu wykluczenia tej możliwości wskazane jest wykonanie control colonoscopy (Baszuk i wsp., 2021).
| Element | Group | Norm [µg/l] | Publication/ Patent application number |
| Selenium | Women | 95-102,5 | Lener M, 2016 Lubiński JA, 2018 Lubiński J, 20118 Pietrzak S, 2019 Szwiec M, 2021 Rogoża-Janiszewska E., 2021 P.437046 |
| Men | 95-102,5 | ||
| Person under 18 years of age | NZ* | – | |
| Arsenic | Women | NZ* | – |
| Men | 0,75-1,0 | P.437046 | |
| Person under 18 years of age | NZ* | – | |
| Zinc | - | 1025-1175 | Lubiński J, 2021 P.434767 P.437046 |
| Person under 18 years of age | NZ* | – | |
| Copper | - | <1000 ≤ 900 | P.436999 |
| Person under 18 years of age | NZ* | – | |
| Manganese | Women | 1-10 | P.438040 |
| Men | NZ* | – | |
| Person under 18 years of age | NZ* | – | |
| Chromium | Women | >0,5 | P.438042 |
| Men | NZ* | – | |
| Person under 18 years of age | NZ* | – |
Recommended element concentrations
The following standards were established on the basis of the Center's own research. Optimal concentration ranges are correlated with a reduced risk of cancer in adults (over 18 years of age). For more information about our research, please read our research.
Elemental norms have not yet been established for some groups of patients based on prospective observations of cohorts of Polish patients. We mark this situation as "NZ". These relationships may be observed as a result of further work. Before choosing the type of elements to be tested, please read the table of current standards.
In patients under 18 years of age, the optimal concentration of elements has not yet been determined in the Polish population.
Ostatnia aktualizacja – 5.10.2026 r.
| Element | Group | Subgroup | Norm [µg/l] | Publication/Patent application number |
| Selenium | Women BRCA1 (-) | – | 113-130 | P.456891 |
| Women BRCA1 (+) | < 50 yo | 96-102 | P.439318 | |
| > 50 yo | 95-120 | |||
| Men | – | 115-130 | P.456890 | |
| Person under 18 years of age | – | 64-110 | Katarina Osman, et al. Clinical Biochemistry (Vol. 31, No. 8, 657-665, 1998) | |
| Arsenic * | Women BRCA1 (-) | – | < 0,6 | Marciniak W., 2020, P.439315 |
| Women BRCA1 (+) | – | < 0,85 | Marciniak W., 2021 | |
| Men | – | 0,7-1,14 | Pat.243835 | |
| Person under 18 years of age | – | NZ* | – | |
| Cadmium | Women BRCA1 (-) | – | <0,6 | Pat.243866 |
| Smokers | 0,87-1,23 | |||
| Women BRCA1 (+) | – | < 0,27 | Pat.237085 | |
| Men | – | < 0,21 | Pat.243863 | |
| Person under 18 years of age | – | NZ* | – | |
| Zinc | Women BRCA1 (-) | – | 5600-6100 | Pat.243832 |
| Women BRCA1 (+) | Non-smokers | 6000-6700 | P.439319 | |
| Smokers | 6400-6800 | |||
| Men | – | 6000-6500 | Pat.243833 | |
| Person under 18 years of age | – | NZ* | – | |
| Copper ** | Women BRCA1 (-) | < 50 yo | 850-1000 | P.438572 |
| > 50 yo | < 1000 | |||
| Women BRCA1 (+) | Non-smokers < 50 yo | 750-825 | ||
| Non-smokers > 50 yo | < 1000 | |||
| Smokers | < 1000 | |||
| Men | – | < 800 | Pat.243834 | |
| Person under 18 years of age | – | NZ* | – | |
| Lead | Women BRCA1 (-) | – | ≤ 7,5 | P.438655 |
| Women BRCA1 (+) | – | < 8 | P.433150 | |
| Men | – | < 13,5 | Pat.243865 | |
| Person under 18 years of age | – | NZ* | – |
- NZ - so far, no correlation has been found between the concentration of the element and the risk of cancer in this clinical subgroup
- Women BRCA1 (-) – women without a detected mutation in the BRCA1 gene
- Women BRCA1 (+) – women with a detected mutation in the BRCA1 gene
- Non-smokers
- Smokers
- * Level of arsenic below 0.6 µg/l in the blood in women over 40 years of age may be the expected concentration if a diet low in arsenic is used, but it may also be a parameter/marker indicating the developing malignant tumor of the large intestine. It is recommended to do this to rule out this possibility control colonoscopy (Baszuk i wsp., 2021).
- ** Level of copper powyżej 1000 µg/l we krwi u kobiet oraz stężenie miedzi powyżej 800 µg/l we krwi u mężczyzn może wskazywać na rozwijający się nowotwór złośliwy jelita grubego. W celu wykluczenia tej możliwości wskazane jest wykonanie control colonoscopy (Baszuk i wsp., 2021).
| Element | Group | Norm [µg/l] | Publication/ Patent application number |
| Selenium | Women | 95-102,5 | Lener M, 2016 Lubiński JA, 2018 Lubiński J, 20118 Pietrzak S, 2019 Szwiec M, 2021 Rogoża-Janiszewska E., 2021 P.437046 |
| Men | 95-102,5 | ||
| Person under 18 years of age | NZ* | – | |
| Arsenic | Women | NZ* | – |
| Men | 0,75-1,0 | P.437046 | |
| Person under 18 years of age | NZ* | – | |
| Zinc | - | 1025-1175 | Lubiński J, 2021 P.434767 P.437046 |
| Person under 18 years of age | NZ* | – | |
| Copper | - | <1000 ≤ 900 | P.436999 |
| Person under 18 years of age | NZ* | – | |
| Manganese | Women | 1-10 | P.438040 |
| Men | NZ* | – | |
| Person under 18 years of age | NZ* | – | |
| Chromium | Women | >0,5 | P.438042 |
| Men | NZ* | – | |
| Person under 18 years of age | NZ* | – |
Address
Grzepnica, ul. Alabastrowa 8
72-003 Dobra (Szczecińska)
72-003 Dobra (Szczecińska)
Phone
Tel: 91 433 42 56
Fax: 91 852 44 33
Fax: 91 852 44 33
office@read-gene.com
laboratory@read-gene.com
laboratory@read-gene.com
Read-Gene S.A. © 2021 | Regulamin Strony | Polityka prywatności | Projekt i realizacja: Market Link
Address
Grzepnica, ul. Alabastrowa 8
72-003 Dobra (Szczecińska)
72-003 Dobra (Szczecińska)
Phone
Tel: 91 433 42 56
Fax: 91 852 44 33
Fax: 91 852 44 33
office@read-gene.com
laboratory@read-gene.com
laboratory@read-gene.com
Read-Gene S.A. © 2021 | Regulamin Strony | Polityka prywatności | Projekt i realizacja: Market Link